|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$268,745
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-03
|
$699,897
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-10
|
$21,619,997
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
Barr, Frederic
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-03
|
$693,281
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$560,999
|
Steinberg, Seth
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016086-40
|
$7,160,362
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-40S1
|
$125,000
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-40S2
|
$116,771
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-40S3
|
$140,249
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-40S4
|
$76,560
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-40S5
|
$35,513
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016042-41
|
$4,295,192
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA047904-28S1
|
$115,192
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S2
|
$60,000
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S3
|
$199,837
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S4
|
$749,690
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-28
|
$5,129,654
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
5U54CA190155-03
|
$698,718
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$240,777
|
Engels, Eric
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$311,605
|
McKinnon, Katherine
|
CCR (NCI)
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
1R44CA206788-01
|
$232,464
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$457,274
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV
|
5R21CA189703-02
|
$200,970
|
QU, ZHAOXIA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$287,033
|
Burke, Terrence
|
CCR (NCI)
|
|
Development of a Small Molecule Inhibitor for KSHV LANA
|
5R01CA186775-03
|
$394,250
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Development of a Vaccine for HIV-AIDS: Cellular Immunity
|
ZIA BC 011062
|
$269,745
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Humoral Immunity
|
ZIA BC 011058
|
$2,157,963
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$269,745
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$18,291
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Discovery and Characterization of New Human Cancer Viruses
|
1R35CA197463-01
|
$916,710
|
MOORE, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA136367-07
|
$342,543
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,069,955
|
Pavlakis, George
|
CCR (NCI)
|
|
Early Events in KSVH Infection of Primary B-cells
|
4P01CA174439-04
|
$1,746,424
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Early events of in vitro KSHV infection
|
4R01CA168472-05
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
1UH2CA202723-01
|
$500,000
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$1,047,897
|
Carrington, Mary
|
CCR (NCI)
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$452,468
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$869,541
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-17
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Persistence of KSHV
|
4R01CA171979-04
|
$298,800
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
|
5R01CA179921-02
|
$395,372
|
MOSES, ASHLEE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
2P01CA019014-37
|
$1,811,800
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|